We are live on
!
Find out more
LCG
Lisanti Capital Growth Portfolio holdings
AUM
$397M
1-Year Est. Return
178.66%
This Fund
S&P 500
This Quarter
Est. Return
+22.39%
1 Year Est. Return
+178.66%
3 Year Est. Return
+1,089.72%
5 Year Est. Return
+3,176.57%
10 Year Est. Return
+120,936.2%
AUM
$808M
AUM Growth
+$28.1M
(+3.6%)
Cap. Flow
-$73M
Cap. Flow
% of AUM
-9.03%
Top 10 Holdings %
Top 10 Hldgs %
19.87%
Holding
167
New
45
Increased
29
Reduced
50
Closed
37
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lattice Semiconductor
LSCC
|
+$13.2M |
| 2 |
Azenta
AZTA
|
+$11.7M |
| 3 |
Asana
ASAN
|
+$11.1M |
| 4 |
Fate Therapeutics
FATE
|
+$9.15M |
| 5 |
Revolve Group
RVLV
|
+$8.52M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Inspire Medical Systems
INSP
|
+$15M |
| 2 |
Allegiant Air
ALGT
|
+$11.9M |
| 3 |
Halozyme
HALO
|
+$11M |
| 4 |
Oshkosh
OSK
|
+$10.4M |
| 5 |
Pacira BioSciences
PCRX
|
+$10.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 31.65% |
| 2 | Technology | 26.22% |
| 3 | Industrials | 16.12% |
| 4 | Consumer Discretionary | 15.73% |
| 5 | Materials | 2.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SMAR
126
DELISTED
Smartsheet Inc.
SMAR
| $1.36M | 0.17% |
+18,795
| New | +$1.17M |
|
|
127
Pacira BioSciences
PCRX
$979M
| $1.3M | 0.16% |
21,365
-161,740
| -88% | -$10.2M |
|
128
RH
RH
$3.7B
| $1.27M | 0.16% |
+1,870
| New | +$1.21M |
|
129
SkinHealth Systems
SKIN
$91.4M
| $1.13M | 0.14% |
+66,950
| New | +$916K |
|
130
Repligen
RGEN
$8.95B
| $1.04M | 0.13% |
5,215
-7,495
| -59% | -$1.45M |
|
131
Ameris Bancorp
ABCB
$5.97B
| – | – |
-140,900
| Closed | -$7.4M |
|
132
Astec Industries
ASTE
$1.04B
| – | – |
-123,169
| Closed | -$9.29M |
|
133
Brunswick
BC
$5.43B
| – | – |
-38,960
| Closed | -$3.72M |
|
|
BLD
134
DELISTED
TopBuild
BLD
| – | – |
-27,396
| Closed | -$5.74M |
|
135
BioXcel Therapeutics
BTAI
$26M
| – | – |
-5,814
| Closed | -$4.01M |
|
136
Citi Trends
CTRN
$606M
| – | – |
-91,465
| Closed | -$7.66M |
|
137
Brinker International
EAT
$9.69B
| – | – |
-50,515
| Closed | -$3.59M |
|
138
Enphase Energy
ENPH
$5.15B
| – | – |
-10,008
| Closed | -$1.62M |
|
139
G-III Apparel Group
GIII
$1.54B
| – | – |
-204,365
| Closed | -$6.16M |
|
|
140
Halozyme
HALO
$9.91B
| – | – |
-263,460
| Closed | -$11M |
|
|
141
Inspire Medical Systems
INSP
$1.73B
| – | – |
-72,631
| Closed | -$15M |
|
142
iShares Russell 2000 Growth ETF
IWO
$14.9B
| – | – |
-1,045
| Closed | -$314K |
|
|
TBHC
143
DELISTED
The Brand House Collective
TBHC
| – | – |
-121,385
| Closed | -$3.41M |
|
144
Lithia Motors
LAD
$8.1B
| – | – |
-20,398
| Closed | -$7.96M |
|
145
Live Oak Bancshares
LOB
$2.03B
| – | – |
-128,325
| Closed | -$8.79M |
|
146
Lightspeed Commerce
LSPD
$1.34B
| – | – |
-53,340
| Closed | -$3.35M |
|
147
Pulmonx
LUNG
$83.6M
| – | – |
-132,260
| Closed | -$6.05M |
|
148
Malibu Boats
MBUU
$575M
| – | – |
-51,820
| Closed | -$4.13M |
|
149
MACOM Technology Solutions
MTSI
$20.1B
| – | – |
-125,629
| Closed | -$7.29M |
|
150
MaxLinear
MXL
$6.12B
| – | – |
-114,757
| Closed | -$3.91M |
|
Similar funds
PIM
EH
TPWA
STT
VC
CF
IVLAV
MHC
Lisanti Capital Growth's Q2 2021 Portfolio in Review
As of Q2 2021, Lisanti Capital Growth held 167 positions worth $808M, up 3.6% from $779M the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Lisanti Capital Growth withdrew a net $73M in Q2 2021, closing 37 positions and reducing 50 holdings. Its most notable exit was Inspire Medical Systems, an estimated $15M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 32% of assets, up from 27% a quarter earlier, followed by Technology and Industrials.
Against the trend, Lisanti Capital Growth opened a new position in Lattice Semiconductor worth $14.5M.
- Lisanti Capital Growth's largest Q2 2021 buy was Lattice Semiconductor: 258,275 shares worth $14.5M.
- Lisanti Capital Growth added most to Fate Therapeutics in Q2 2021, an estimated $9.15M increase.
- Lisanti Capital Growth's biggest Q2 2021 reduction was Allegiant Air, cutting an estimated $11.9M.
- Lisanti Capital Growth fully exited Inspire Medical Systems in Q2 2021, selling an estimated $15M.
- Lisanti Capital Growth's ten largest holdings make up 20% of its $808M portfolio in Q2 2021.
- Lisanti Capital Growth opened 45 new positions and closed 37 in Q2 2021.
- Lisanti Capital Growth's portfolio value rose 3.6% quarter-over-quarter to $808M.
Based on Lisanti Capital Growth's 13F filing for Q2 2021, filed 16 Aug 2021.